Clinical Trial Update: A Long Term Study of Clozapine in Patients With Treatment-resistant Schizophrenia [Phase 2]

View source ↗

Summary

A Phase 2 long-term study assessing clozapine in patients with treatment-resistant schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Clozapine (Clozapine)

Snippet

Sponsor: Novartis | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED